{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:58:13Z","timestamp":1793825893961,"version":"4.6.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> One hundred thirty-four MDS patients were assessed for the prevalence of autoinflammatory complications and its link with karyotypes and somatic mutation status. Autoinflammatory complications were described either as well-defined autoinflammatory diseases (AD) or undifferentiated \u201cautoinflammatory disease\u201d (UAD) (defined as CRP over 10.0 mg\/L on five consecutive occasions, taken at separate times and not explained by infection). Several patient characteristics including demographic, clinical, laboratory, cytogenetics charts, and outcomes, were compared between different groups.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Sixty-two (46.3%) patients had an autoinflammatory complication manifesting as arthralgia (43.5% <jats:italic>vs<\/jats:italic>. 23.6%, <jats:italic>p<\/jats:italic> = 0.0146), arthritis (30.6% <jats:italic>vs<\/jats:italic>. 15.3%, <jats:italic>p<\/jats:italic> = 0.0340), skin rash (27.4% <jats:italic>vs<\/jats:italic>. 12.5%, <jats:italic>p<\/jats:italic> = 0.0301), pleuritis (14.5% <jats:italic>vs<\/jats:italic>. 4.2%, <jats:italic>p<\/jats:italic> = 0.0371) and unexplained fever (27.4% <jats:italic>vs<\/jats:italic>. 0%, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001). AD were found in 7.4% of MDS patients (with polymyalgia rheumatic being the most frequently one). Classical autoimmune diseases were found only in 4 MDS patients (3.0%). Transcription factor pathway mutations (<jats:italic>RUNX1, BCOR, WTI, TP53<\/jats:italic>) (OR 2.20 [95%CI 1.02\u20134.75], <jats:italic>p<\/jats:italic> = 0.0451) and abnormal karyotypes (OR 2.76 [95%CI 1.22\u20136.26], <jats:italic>p<\/jats:italic> = 0.0153) were associated with autoinflammatory complications. Acute leukaemic transformation was more frequent in MDS patients with autoinflammatory features than those without (27.4% <jats:italic>vs<\/jats:italic>. 9.7%, <jats:italic>p<\/jats:italic> = 0.0080).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Autoinflammatory complications are common in MDS. Somatic mutations of transcription factor pathways and abnormal karyotypes are associated with greater risk of autoinflammatory complications, which are themselves linked to malignant transformation and a worse prognosis.<\/jats:p>","DOI":"10.3389\/fimmu.2021.610019","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T22:50:59Z","timestamp":1613861459000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication"],"prefix":"10.3389","volume":"12","author":[{"given":"Abdulla","family":"Watad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kacar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Luigi","family":"Bragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Jassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","article-title":"Myelodysplastic syndromes","volume":"383","author":"Ad\u00e8s","year":"2014","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood-2007-03-079681","article-title":"Hematopoietic cytokines","volume":"111","author":"Metcalf","year":"2008","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fimmu.2016.00390","article-title":"The role of toll-like receptors in hematopoietic malignancies","volume":"7","author":"Monlish","year":"2016","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2016.00151","article-title":"Unraveling the pathogenesis of MDS: the NLRP3 inflammasome and pyroptosis drive the MDS phenotype","volume":"6","author":"Sallman","year":"2016","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fimmu.2016.00502","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukemia","volume":"464","author":"Raaijmakers","year":"2012","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1136\/annrheumdis-2017-211473","article-title":"A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever","volume":"76","author":"Moghaddas","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00277-018-3302-0","article-title":"Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes","volume":"97","author":"Montoro","year":"2018","journal-title":"Ann Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.beha.2013.09.003","article-title":"Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?","volume":"26","author":"Braun","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000446062","article-title":"Autoimmunity and inflammation in myelodysplastic syndromes","volume":"136","author":"Wolach","year":"2016","journal-title":"Acta Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","article-title":"Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"105","author":"Arends","year":"2020","journal-title":"Haematologica"},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-018-0107-2","article-title":"Clonal hematopoiesis in patients with rheumatoid arthritis","volume":"8","author":"Savola","year":"2018","journal-title":"Blood Cancer J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","article-title":"Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients","volume":"80","author":"Zhang","year":"2019","journal-title":"Exp Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1365-2141.2009.08010.x","article-title":"The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research","volume":"148","author":"Smith","year":"2010","journal-title":"Br J Haematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.rdc.2020.03.001","article-title":"Autoimmunity, clonal hematopoiesis, and myeloid neoplasms","volume":"46","author":"Bekele","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"B23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/rmdopen-2018-000694","article-title":"Polymyalgia rheumatica: an autoinflammatory disorder?","volume":"4","author":"Floris","year":"2018","journal-title":"RMD Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2018-08-867333","article-title":"The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis","volume":"133","author":"Cargo","year":"2019","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/10428190902780677","article-title":"Autoimmunity and hematologic malignancies: associations and mechanisms","volume":"50","author":"Martin","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1073\/pnas.0702975104","article-title":"NRAS mutation causes a human autoimmune lymphoproliferative syndrome","volume":"104","author":"Oliveira","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2337\/diabetes.54.5.1423","article-title":"Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function","volume":"54","author":"Zheng","year":"2005","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0002-9440(10)64356-8","article-title":"Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis","volume":"160","author":"Yamanishi","year":"2002","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e3091","DOI":"10.1097\/MD.0000000000003091","article-title":"Certain autoimmune manifestations are associated with distinctive karyotypes and outcomes in patients with myelodysplastic syndrome: a retrospective cohort study","volume":"95","author":"Lee","year":"2016","journal-title":"Med (United States)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.4047","article-title":"Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9","volume":"22","author":"Schneider","year":"2016","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"E280","DOI":"10.1002\/ajh.24333","article-title":"Autoimmune diseases and myelodysplastic syndromes","volume":"91","author":"Komrokji","year":"2016","journal-title":"Am J Hematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.autrev.2018.07.009","article-title":"Autoimmune diseases in myelodysplastic syndrome favors patients survival: a case control study and literature review","volume":"18","author":"Seguier","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a french multicentre retrospective study","volume":"55","author":"Mekinian","year":"2015","journal-title":"Rheumatol (United Kingdom)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/acr.20504","article-title":"Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study","volume":"63","author":"de Hollanda","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s40674-016-0043-x","article-title":"Giant cell arteritis: from pathogenesis to therapeutic management","volume":"2","author":"Watanabe","year":"2016","journal-title":"Curr Treat Options Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1080\/10428194.2018.1543885","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes","volume":"60","author":"Abuhadra","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders","volume":"122","author":"Damm","year":"2013","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00277-012-1521-3","article-title":"Activating CBL mutations are associated with a distinct MDS\/MPN phenotype","volume":"91","author":"Schwaab","year":"2012","journal-title":"Ann Hematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","article-title":"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes","volume":"119","author":"Thol","year":"2012","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"106948","DOI":"10.18632\/oncotarget.22157","article-title":"Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes","volume":"8","author":"Cedena","year":"2017","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.leukres.2019.03.001","article-title":"Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis","volume":"80","author":"Du","year":"2019","journal-title":"Leuk Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2019.385","article-title":"Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome","author":"Jung","year":"2020","journal-title":"Korean J Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.610019\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T22:51:03Z","timestamp":1613861463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.610019\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2021.610019"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.610019","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"article-number":"610019"}}